• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白血病治疗用材料技术的最新进展

Recent Advances in Material Technology for Leukemia Treatments.

机构信息

State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, China.

Key Laboratory of Biopharmaceutical Preparation and Delivery, Chinese Academy of Sciences, Beijing, 100190, China.

出版信息

Adv Mater. 2024 Jun;36(26):e2313955. doi: 10.1002/adma.202313955. Epub 2024 Apr 12.

DOI:10.1002/adma.202313955
PMID:38547845
Abstract

Leukemia is a widespread hematological malignancy characterized by an elevated white blood cell count in both the blood and the bone marrow. Despite notable advancements in leukemia intervention in the clinic, a large proportion of patients, especially acute leukemia patients, fail to achieve long-term remission or complete remission following treatment. Therefore, leukemia therapy necessitates optimization to meet the treatment requirements. In recent years, a multitude of materials have undergone rigorous study to serve as delivery vectors or direct intervention agents to bolster the effectiveness of leukemia therapy. These materials include liposomes, protein-based materials, polymeric materials, cell-derived materials, and inorganic materials. They possess unique characteristics and are applied in a broad array of therapeutic modalities, including chemotherapy, gene therapy, immunotherapy, radiotherapy, hematopoietic stem cell transplantation, and other evolving treatments. Here, an overview of these materials is presented, describing their physicochemical properties, their role in leukemia treatment, and the challenges they face in the context of clinical translation. This review inspires researchers to further develop various materials that can be used to augment the efficacy of multiple therapeutic modalities for novel applications in leukemia treatment.

摘要

白血病是一种广泛存在的血液恶性肿瘤,其特征是血液和骨髓中的白细胞计数升高。尽管在临床中白血病干预取得了显著进展,但很大一部分患者,尤其是急性白血病患者,在治疗后无法实现长期缓解或完全缓解。因此,白血病的治疗需要优化以满足治疗需求。近年来,大量材料经过严格研究,被用作递送载体或直接干预剂,以提高白血病治疗的效果。这些材料包括脂质体、基于蛋白质的材料、聚合物材料、细胞衍生材料和无机材料。它们具有独特的特性,并应用于广泛的治疗方式,包括化疗、基因治疗、免疫治疗、放射治疗、造血干细胞移植和其他不断发展的治疗方法。在这里,对这些材料进行了概述,描述了它们的物理化学性质、在白血病治疗中的作用以及在临床转化中面临的挑战。这篇综述激发了研究人员进一步开发各种材料的兴趣,这些材料可用于增强多种治疗方式的疗效,从而为白血病治疗的新应用提供新的机会。

相似文献

1
Recent Advances in Material Technology for Leukemia Treatments.白血病治疗用材料技术的最新进展
Adv Mater. 2024 Jun;36(26):e2313955. doi: 10.1002/adma.202313955. Epub 2024 Apr 12.
2
Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies.急性白血病的骨髓移植:最新进展及与其他疗法的比较
Semin Hematol. 1987 Jan;24(1):55-67.
3
Nanomedicines for the treatment of hematological malignancies.用于治疗血液系统恶性肿瘤的纳米药物。
J Control Release. 2018 Oct 10;287:194-215. doi: 10.1016/j.jconrel.2018.08.034. Epub 2018 Aug 28.
4
Autologous bone marrow transplantation for leukemia.白血病的自体骨髓移植
Semin Oncol. 1993 Oct;20(5 Suppl 6):40-54.
5
Natural Ingredient-Based Polymeric Nanoparticles for Cancer Treatment.基于天然成分的聚合物纳米粒子用于癌症治疗。
Molecules. 2020 Aug 9;25(16):3620. doi: 10.3390/molecules25163620.
6
[Recent progress in the treatment of acute leukemia].[急性白血病治疗的最新进展]
Gan To Kagaku Ryoho. 2003 Jul;30(7):895-901.
7
Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.Blinatumomab 与化疗治疗高危初发 B 细胞急性淋巴细胞白血病患儿无事件生存的效果:一项随机临床试验。
JAMA. 2021 Mar 2;325(9):843-854. doi: 10.1001/jama.2021.0987.
8
Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. The Acute Lymphoblastic Leukemia Working Committee.急性淋巴细胞白血病首次缓解期成人患者接受化疗或骨髓移植后的长期随访。急性淋巴细胞白血病工作委员会。
Ann Intern Med. 1995 Sep 15;123(6):428-31. doi: 10.7326/0003-4819-123-6-199509150-00006.
9
Blastic plasmacytoid dendritic cell neoplasm should be treated with acute leukemia type induction chemotherapy and allogeneic stem cell transplantation in first remission.原始浆细胞样树突状细胞瘤应以急性白血病诱导化疗和缓解后异基因造血干细胞移植治疗。
Int J Hematol. 2010 Sep;92(2):398-400. doi: 10.1007/s12185-010-0655-0. Epub 2010 Aug 11.
10
Progress in CLL, chemotherapy, antibodies and transplantation.慢性淋巴细胞白血病、化疗、抗体及移植方面的进展
Biomed Pharmacother. 2001 Nov;55(9-10):524-8. doi: 10.1016/s0753-3322(01)00139-1.

引用本文的文献

1
World Health Organization (WHO)'s vision for a leukemia-free Africa: opportunities and challenges- a narrative review.世界卫生组织(WHO)关于非洲无白血病的愿景:机遇与挑战——一篇叙述性综述
Ann Med Surg (Lond). 2025 Jul 11;87(9):5661-5677. doi: 10.1097/MS9.0000000000003553. eCollection 2025 Sep.
2
Advancing Leukemia Diagnosis and Treatment: WHO-Supported Laboratory Innovations in Africa- A Narrative Review.推进白血病诊断与治疗:世界卫生组织支持的非洲实验室创新——一篇叙述性综述
Blood Lymphat Cancer. 2025 Jun 24;15:47-67. doi: 10.2147/BLCTT.S518005. eCollection 2025.
3
Nanotechnology in leukemia therapy: revolutionizing targeted drug delivery and immune modulation.
白血病治疗中的纳米技术:革新靶向药物递送与免疫调节
Clin Exp Med. 2025 May 17;25(1):166. doi: 10.1007/s10238-025-01686-z.
4
Anti-IL-1RAP scFv-mSA-S19-TAT fusion carrier as a multifunctional platform for versatile delivery of biotinylated payloads to myeloid leukemia cells.抗白细胞介素 1 受体相关蛋白单链抗体-mSA-S19-TAT 融合载体作为一种多功能平台,可将生物素化有效载荷递送至髓系白血病细胞。
Sci Rep. 2024 Oct 23;14(1):25080. doi: 10.1038/s41598-024-76851-7.
5
Application and research progress of single cell sequencing technology in leukemia.单细胞测序技术在白血病中的应用及研究进展
Front Oncol. 2024 Aug 29;14:1389468. doi: 10.3389/fonc.2024.1389468. eCollection 2024.
6
Advancements in the impact of human microbiota and probiotics on leukemia.人类微生物群和益生菌对白血病影响的研究进展。
Front Microbiol. 2024 Jul 3;15:1423838. doi: 10.3389/fmicb.2024.1423838. eCollection 2024.